Want to know what it's like to study this course at uni? We've got all the key info, from entry requirements to the modules on offer. If that all sounds good, why not check out reviews from real students or even book onto an upcoming open days?
MSc - Master of Science
Holloway
Full Time
FEB-25
1 year
Select a course option
MSc - Master of Science
Holloway
Full Time
FEB-25
1 year
MSc - Master of Science
Holloway
Part Time
FEB-25
2 years
Select a subject
Select a an exam type
Why study this course?
Our Cancer Immunotherapy master's will teach you about conventional cancer therapies including surgery, radiation and chemotherapy. You’ll have access to highly qualified researchers and teachers in pharmacology and immunology, as well as those from our Cellular and Molecular Immunology Research Centre. We’ll encourage you to join professional societies so you can improve your CV and build upon the impressive skills you’ll already have developed from research projects on the course. By the end of this postgraduate course, you’ll come to understand why investigators and oncologists now believe immunotherapy combined with pharmacological treatments will soon provide curative therapies that can give patients a new lease of life.
More about this course
The Cancer Immunotherapy MSc will introduce you to the advancement of treatments that are fighting to prolong the lives of cancer patients. Cancer is increasing worldwide, and by 2030 there are expected to be 22 million new cases per year. By the end of this course, you’ll be ready for employment as a professional who can help to tackle this global challenge.
We’ll provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, as well as the current evolution of drug therapies. This will help you review the biology of cancer, taking pathological considerations into account, and the molecular changes within cells which are associated with the progression of the disease.
You’ll enhance your intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data. This means you’ll cover new areas in immunotherapy as well as existing pharmacological therapies including (but not limited to) monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; adoptive T cell therapy; dendritic cell vaccines; microbial causes of cancer; adjuvant development for vaccines; epigenetics and cancer; immuno-chemotherapy; dendritic cell vaccine development; the ageing immune system and immunotherapy; natural killer cells/tumour-associated macrophages and cancer immunotherapy and Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis.
The teaching is delivered by highly-qualified researchers and teachers in pharmacology and immunology, including those from our Cellular and Molecular Immunology Research Centre. Skills gained from research projects will be highly marketable in industry, academia and the National Health Service (NHS), and you’ll also be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.
Assessment
Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.
Where this course can take you
As a graduate of this course, you’ll be well prepared to work for companies that are developing cancer immunotherapies. Such companies include global biopharmaceutical company Bristol-Myers Squibbs, MERCK, AstraZeneca and Roche. There are also an an ever-growing number of start-up companies that are tackling cancer, including Vyriad, UNUM Therapeutics and Alpine Immune Sciences.
You’ll also have ample opportunity for future postgraduate study within the School of Human Sciences and the Cellular and Molecular Immunology Research Centre at the MPhil/PhD level, as well as research opportunities with partners within the UK, Europe and the rest of the world.
You will be required to have: at least a lower second (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics (these will be considered on an individual basis).
Students living in
Domestic
£10,500 per year
Students from Domestic
Jan-2024: £9,300 per year; Sep-2024: £10,500 per year
£18,150 per year
Students from EU
The amount you'll pay if you come to study here from somewhere in the EU.
£18,150 per year
Students from International
The amount you'll pay if you come to study here from a country outside the EU.
London Metropolitan University is home to a diverse community of learners, mentors, practitioners, innovators, and thinkers, located in...
Check out our
London city guide